Vancomycin is an antibiotic used for the treatment of systemic infections. It is given intravenously usually every twelve or twenty-four hours. This particular drug has a medium level of boundedness, with approximately fty percent of the drug being free and thus physiologically eective. A physiologically-based pharmacokinetic (PBPK) model was used to better understand the absorption, distribution, and elimination of the drug. Using optimal parameters, the model could be used in the future to test how various factors, such as BMI or excretion levels, might aect the concentration of the antibiotic
In individualized therapy, the Bayesian approach integrated with population pharmacokinetic models (...
The aims of this study were to develop a population pharmacokinetic model of vancomycin in adult pat...
Objective: Vancomycin is commonly used in postoperative neurosurgical patients for empirical anti-in...
An evaluation of vancomycin pharmacokinetics was performed in 2 phases. In phase I, a vancomycin pop...
To analyze microbiological effectiveness of vancomycin in children from a pediatric hospital through...
Introduction. Vancomycin is a glycopeptide antibiotic active against numerous gram-positive bacteria...
Introduction: While vancomycin remains a widely prescribed antibiotic, it can cause ototoxicity and ...
The importance of closely observing patients receiving antibiotic therapy, performing therapeutic dr...
This study aimed to investigate the effect of a structural pharmacokinetic (PK) model with fewer com...
The paper presents and discusses a basic pharmacokinetic model for vancomycin, an antibiotic that is...
Vancomycin is a tricyclic glycopeptide antibiotic, mostly used in the treatment of severe staphyloco...
Levofloxacin is in a class of antibiotics known as fluoroquinolones, which treat infections by killi...
Ertapenem is an antibiotic commonly used to treat a broad spectrum of infections, which is part of a...
The development and evaluation of a vancomycin population pharmacokinetic model in children, pre-ado...
Class of 2005 AbstractObjectives: Doses of vancomycin are frequently estimated using various predict...
In individualized therapy, the Bayesian approach integrated with population pharmacokinetic models (...
The aims of this study were to develop a population pharmacokinetic model of vancomycin in adult pat...
Objective: Vancomycin is commonly used in postoperative neurosurgical patients for empirical anti-in...
An evaluation of vancomycin pharmacokinetics was performed in 2 phases. In phase I, a vancomycin pop...
To analyze microbiological effectiveness of vancomycin in children from a pediatric hospital through...
Introduction. Vancomycin is a glycopeptide antibiotic active against numerous gram-positive bacteria...
Introduction: While vancomycin remains a widely prescribed antibiotic, it can cause ototoxicity and ...
The importance of closely observing patients receiving antibiotic therapy, performing therapeutic dr...
This study aimed to investigate the effect of a structural pharmacokinetic (PK) model with fewer com...
The paper presents and discusses a basic pharmacokinetic model for vancomycin, an antibiotic that is...
Vancomycin is a tricyclic glycopeptide antibiotic, mostly used in the treatment of severe staphyloco...
Levofloxacin is in a class of antibiotics known as fluoroquinolones, which treat infections by killi...
Ertapenem is an antibiotic commonly used to treat a broad spectrum of infections, which is part of a...
The development and evaluation of a vancomycin population pharmacokinetic model in children, pre-ado...
Class of 2005 AbstractObjectives: Doses of vancomycin are frequently estimated using various predict...
In individualized therapy, the Bayesian approach integrated with population pharmacokinetic models (...
The aims of this study were to develop a population pharmacokinetic model of vancomycin in adult pat...
Objective: Vancomycin is commonly used in postoperative neurosurgical patients for empirical anti-in...